Valuation: Medicover AB

Market Cap 369.2Cr 413.44Cr 341.07Cr 309.09Cr 578.26Cr 39TCr 587.83Cr 4.1TCr 1.62TCr 21TCr 1.55TCr 1.52TCr 65TCr P/E 2026 *
15.2x
P/E 2027 * 28.7x
Enterprise Value 420.36Cr 470.73Cr 388.33Cr 351.92Cr 658.39Cr 45TCr 669.28Cr 4.67TCr 1.85TCr 23TCr 1.77TCr 1.73TCr 74TCr EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.59x
Free-Float
44.91%
Yield 2026 *
0.92%
Yield 2027 * 1.14%

Last Transcript: Medicover AB

3 years 21.54
Extreme 21.54
21.54
5 years 16.55
Extreme 16.55
21.54
10 years 8.7
Extreme 8.7
21.54
Manager TitleAgeSince
Chief Executive Officer 58 01/05/2025
Director of Finance/CFO - 01/10/2024
Chief Tech/Sci/R&D Officer - 01/07/2025
Director TitleAgeSince
Director/Board Member 63 01/01/1997
Chairman 55 01/01/2017
Director/Board Member 86 01/01/2007
Change 5-day change 1-year change 3-year change Capi.($)
+30.15%-.--% - - 413.63Cr
-1.16%+1.13%+15.22%+35.39% 12TCr
+1.01%+2.94%+7.31%+96.04% 10TCr
+1.03%+2.94%+107.70%+910.50% 5.96TCr
+2.30%+2.61%-6.79%+78.43% 2.86TCr
+0.15%+3.40%+32.62%+100.08% 2.69TCr
+0.30%+4.07%+16.51%+67.17% 2.68TCr
-0.22%+1.07%+30.54%+394.15% 2.18TCr
-2.46%-5.71%-23.11%-7.94% 1.96TCr
-1.14%+2.18%+3.47%+81.93% 1.9TCr
Average +3.00%+0.32%+20.38%+195.08% 4.71TCr
Weighted average by Cap. +0.38%+0.61%+24.51%+200.30%

Financials

2026 *2027 *
Net sales 251.6Cr 281.75Cr 232.43Cr 210.64Cr 394.07Cr 27TCr 400.59Cr 2.8TCr 1.11TCr 14TCr 1.06TCr 1.03TCr 44TCr 267.8Cr 299.89Cr 247.4Cr 224.2Cr 419.44Cr 28TCr 426.38Cr 2.98TCr 1.18TCr 15TCr 1.13TCr 1.1TCr 47TCr
Net income 24Cr 27Cr 23Cr 20Cr 38Cr 2.6TCr 39Cr 271.43Cr 107.46Cr 1.36TCr 102.61Cr 100.43Cr 4.29TCr 13Cr 14Cr 12Cr 11Cr 20Cr 1.37TCr 20Cr 142.94Cr 57Cr 716.17Cr 54Cr 53Cr 2.26TCr
Net Debt 51Cr 57Cr 47Cr 43Cr 80Cr 5.44TCr 81Cr 568.71Cr 225.16Cr 2.85TCr 214.99Cr 210.42Cr 8.98TCr 56Cr 63Cr 52Cr 47Cr 88Cr 5.94TCr 89Cr 621.58Cr 246.09Cr 3.11TCr 234.98Cr 229.99Cr 9.82TCr
Projected Income Statement - Annual - Medicover AB
Logo Medicover AB
Medicover AB is a Sweden-based healthcare and diagnostic services provider. It offers a broad range of healthcare services and hub-and-spoke diagnostic laboratory network, supported by proprietary software and information systems infrastructure. The Company offers its services through two divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division offers services ranging from primary care to specialist outpatient and inpatient care. The care is delivered mainly through Medicover’s own network of clinics and medical facilities. The Diagnostic Services division offers a broad range of diagnostic laboratory testing for humans and some veterinary services across all main clinical pathology specialties. The Company focuses primarily on such markets, as Poland, Germany, Romania, Ukraine.
Employees
49,000
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Medicover AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
24.29EUR
Average target price
25.42EUR
Spread / Average Target
+4.65%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Medicover AB